FORGHIERI, Fabio
 Distribuzione geografica
Continente #
NA - Nord America 7.452
EU - Europa 3.126
AS - Asia 855
Continente sconosciuto - Info sul continente non disponibili 14
SA - Sud America 12
AF - Africa 5
OC - Oceania 5
Totale 11.469
Nazione #
US - Stati Uniti d'America 7.426
GB - Regno Unito 1.185
IT - Italia 543
SE - Svezia 513
CN - Cina 324
DE - Germania 253
HK - Hong Kong 205
UA - Ucraina 166
FI - Finlandia 140
TR - Turchia 119
FR - Francia 100
BG - Bulgaria 68
SG - Singapore 55
IN - India 52
BE - Belgio 35
CZ - Repubblica Ceca 21
ID - Indonesia 20
VN - Vietnam 20
IE - Irlanda 15
KR - Corea 15
IR - Iran 14
LT - Lituania 14
BZ - Belize 13
CA - Canada 13
EU - Europa 12
RU - Federazione Russa 12
NL - Olanda 11
JP - Giappone 10
ES - Italia 7
CH - Svizzera 6
MY - Malesia 6
AU - Australia 5
DK - Danimarca 5
PL - Polonia 5
RO - Romania 5
SK - Slovacchia (Repubblica Slovacca) 5
AT - Austria 4
BD - Bangladesh 3
BR - Brasile 3
CL - Cile 3
GR - Grecia 3
TW - Taiwan 3
CO - Colombia 2
LB - Libano 2
MA - Marocco 2
MD - Moldavia 2
NO - Norvegia 2
OM - Oman 2
PT - Portogallo 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
IQ - Iraq 1
KH - Cambogia 1
LU - Lussemburgo 1
MK - Macedonia 1
MZ - Mozambico 1
PE - Perù 1
PY - Paraguay 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 11.469
Città #
Fairfield 1.188
Southend 978
Woodbridge 746
Ashburn 678
Chandler 591
Houston 558
Ann Arbor 455
Seattle 443
Cambridge 357
Wilmington 335
Nyköping 331
Jacksonville 328
Dearborn 317
Hong Kong 198
Modena 184
New York 110
Beijing 101
Helsinki 81
San Diego 80
Fremont 73
Bremen 67
Sofia 67
Princeton 66
Eugene 63
Izmir 63
Bologna 38
Redwood City 34
London 32
Brussels 30
Boardman 28
Shanghai 25
Des Moines 24
Milan 23
Jakarta 19
San Jose 19
Singapore 19
Dong Ket 16
Las Vegas 16
Dublin 14
Hefei 14
Albuquerque 13
Belize City 13
Chicago 12
Dallas 12
Kunming 12
Leawood 10
Washington 10
Guangzhou 9
Kilburn 9
Nanjing 9
Pavia 9
Rome 9
Chiswick 8
Norwalk 8
San Mateo 8
Paris 7
Perugia 7
Saint Louis 7
San Francisco 7
Seongnam-si 7
Toronto 7
Wuhan 7
Nanchang 6
Rimini 6
Romainville 6
Bangalore 5
Bengaluru 5
Correggio 5
Phoenix 5
Prescot 5
Tokyo 5
Tulare 5
Castelnuovo Rangone 4
Central 4
Columbus 4
Falls Church 4
Genova 4
Ghent 4
Grafing 4
Hanoi 4
Kosice 4
Los Angeles 4
San Giuliano Milanese 4
Vienna 4
Amsterdam 3
Asti 3
Atlanta 3
Bristol 3
Changsha 3
Chengdu 3
Cresserons 3
Dhaka 3
Florence 3
Formigine 3
Hebei 3
Hounslow 3
Istanbul 3
Jinan 3
Lausanne 3
Lecce 3
Totale 9.158
Nome #
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 274
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 254
Helicobacter pylori infection andchronic immune thrombocytopenic purpura: long-term results of bacteriumeradication and association with bacterium virulence profiles 242
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 237
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 237
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 234
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 225
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 220
Organising pneumonia mimicking invasive fungal disease in patients with leukaemia. 218
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 210
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 204
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 204
Cytarabine-related lung infiltrates on high resolution computerized tomography: a possible complication with benign outcome in leukemic patients. 204
An unusual case of splenomegaly and increased lactate dehydrogenase heralding acute myeloid leukemia with eosinophilia and RUNX1-MECOM fusion transcripts 202
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term Imatinib mesylate treatment. 201
Acute appendicitis in adult neutropenic patients with hematologic malignancies 198
Mucorales-specific T cells in patients with hematologic malignancies 197
Human herpesvirus 6 latency characterized by high viral load: Chromosomal integration in many, but not all, cells 195
Chronic eosinophilic leukaemia with ETV6-NTRK3 fusion transcript in an elderly patient affected with pancreatic carcinoma 195
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 195
Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis 195
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 191
An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells? 190
Epstein-Barr virusassociated pneumonia in an adult patient with severe aplastic anaemia: resolutionafter the transient withdrawal of cyclosporine. 189
B cells and herpesviruses: a model of lymphoproliferation 189
Human Herpesvirus 8 (HHV8) Infection and Related Diseases in Italian Transplant Cohorts. 188
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 188
Diagnosis of invasive aspergillosis by tracking Aspergillus-specific T cells in hematologic patients with pulmonary infiltrates 187
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 187
The importance of cytogenetic and molecular analyses in eosinophilia-associated myeloproliferative neoplasms: an unusual case with normal karyotype and TNIP1- PDGFRB rearrangement and overview of PDGFRB partner genes 185
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 182
Ruxolitinib for pulmonary extramedullary hematopoiesis in myelofibrosis 178
HHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role? 177
How I treat HHV8/KSHV-related diseases in posttransplant patients. 174
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 174
Detection of Pneumocystis jirovecii and Aspergillus spp. DNa in bronchoalveolar lavage fluids by commercial real-time PCr assays: comparison with conventional diagnostic tests 172
Pain and emotional distress in leukemia patients at diagnosis. 170
Variability of Voriconazole Trough Levels in Haematological Patients: Influence of Comedications with cytochrome P450(CYP) Inhibitors and/or with CYP Inhibitors plus CYP Inducers 170
Indirect Antitumor Effects of Mammalian Target of Rapamycin Inhibitors Against Kaposi Sarcoma in Transplant Patients 170
Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. 164
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 162
Mucorles-specific T cells emerge in the course of invasive mucormucosis and may be used as a surrogate diagnostic marker in high-risk patients 162
Inflammatory myofibroblastic tumor of the bone marrow. 161
Philadelphia chromosome-positive acute lymphoblastic leukemia 158
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 158
Interferon-alpha may restore sensitivity to tyrosine-kinase inhibitors in Philadelphia chromosome positive acute lymphoblastic leukaemia with F317L mutation 157
BK virus infection and neurologic dysfunctions in a patient with lymphoma treated with chemotherapy and rituximab 155
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 152
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 152
Splenic hyalohyphomycosis, molecularly and immunologically consistent with invasive aspergillosis, in a patient with acute lymphoblastic leukemia. 148
Severe pneumonia caused by Legionella pneumophila serogroup 11, Italy. 146
Minimal/Measurable Residual Disease Monitoring in NPM1-Mutated Acute Myeloid Leukemia: A Clinical Viewpoint and Perspectives 146
Splenomegaly in hematological malignancies and portal hypertension 141
Safety profile of Erwinia asparaginase treatment in adults with newly diagnosed acute lymphoblastic leukemia: a retrospective monocenter study 141
Investigating the association between physicians self-efficacy regarding communication skills and risk of “burnout” 141
May the correlation between Kit-D816 mutation and AML1-ETO level change the use of prognostic factors in t(8;21) AML? 140
Persistent hiccups as an adverse event to FLAG-IDA regimenfor leukemia. 140
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 139
Identification and characterization of Aspergillus-specific immune responses to diagnose invasive aspergillosis in high risk patients: a multicenter study 132
Ibrutinib Is a Newly Recognized Host Factor for the Definition of Probable Invasive Pulmonary Mold Disease, Based on Off-target Effects, Unrelated to Its B-cell Immunosuppressant Activity 130
Tumor-targeted immunoliposomal nanosystems to deliver either Cidofovir or Antineoplastic SiRNA against Primary Effusion Lymphoma (PEL) 128
"Metodo per la diagnosi e/o il monitoraggio della mucormicosi" - "Method for the diagnosis of and/or monitoring mucormycosis" 124
Acute promyelocytic leukemia in very elderly patients: still aclinical challenge. 123
Pain and emozional distress in hematological patients throughout all phases of disease: results from a multidisciplinary research team in Modena University Hospital 113
β-HHVs and HHV-8 in Lymphoproliferative Disorders. 113
Early palliative/supportive care in acute myeloid leukaemia allows low aggression end-of-life interventions: Observational outpatient study 50
Improved efficacy of quizartinib in combination therapy with PI3K inhibition in primary FLT3-ITD AML cells 33
Edmonton symptom assessment system Global Distress Score and overall survival in acute leukaemia 27
Preclinical Validation of an Advanced Therapy Medicinal Product Based on Cytotoxic T Lymphocytes Specific for Mutated Nucleophosmin (NPM1mut) for the Treatment of NPM1mut-Acute Myeloid Leukemia 25
Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia-like or acute lymphoblastic leukemia-like chemotherapy and impact of allogeneic stem cell transplantation: a Campus ALL study 19
Totale 11.682
Categoria #
all - tutte 41.919
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.919


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019324 0 0 0 0 0 0 0 0 0 0 0 324
2019/20202.653 162 93 100 170 290 410 500 349 250 101 111 117
2020/20212.173 142 132 183 268 231 185 141 251 99 261 141 139
2021/20221.553 69 208 160 96 32 71 85 83 140 145 296 168
2022/20231.765 231 219 109 173 273 203 58 169 163 23 72 72
2023/20241.171 33 48 92 88 215 139 137 210 23 22 77 87
Totale 11.682